Parkinson’s papers
2024
Kim, J. J., Vitale, D., Otani, D. V., Lian, M. M., Heilbron, K., Iwaki, H., ..., the Global Parkinson’s Genetics Program (GP2), ..., Mata, I. (2024). Multi-ancestry genome-wide association meta-analysis of Parkinson’s disease. Nature genetics, 56, 27-36. 10.1038/s41588-023-01584-8
Le Heron, C., Chong, T. (2024). Learning the value of experience. Brain, 147(3), 1127–1129. 10.1093/brain/awae084
2023
Blommer, J., Pitcher, T., Mustapic, M., Eren, E., Yao, P. J., Vreones, M. P., Pucha, K. A., Dalrymple-Alford, J., Shoorangiz, R., Meissner, W. G., Anderson, T., Kapogiannis, D. (2023). Extracellular vesicle biomarkers for cognitive impairment in Parkinson’s disease. Brain, 146(1), 195–208. 10.1093/brain/awac258
Cardoso, F., Goetz, C. G., Mestre, T. A., Sampaio, C., Adler, C. H., Berg, D., ..., ..., Meissner, W.G., ..., ..., Trenkwalder, C. (2023). A statement of the MDS on biological definition, staging, and classification of Parkinson's disease. Movement Disorders. 10.1002/mds.29683
Dalrymple-Alford, J.C., Anderson, T.J., Melzer, T.R. (2023). Thalamus, thalamocortical networks, and non-motor symptoms in Parkinson’s disease. book chapter in Cerebral Cortex and Thalamus XII.
Evangelisti, S., Boessenkool, S., Pflanz, C.P., Basting, R., Betts, J.F., Jenkinson, M., Clare, S., Muhammed, K., Le Heron, C., Armstrong, R., Klein, J.C. (2023). Subthalamic nucleus shows opposite functional connectivity pattern in Huntington’s and Parkinson’s disease. Brain Communications, 5(6), p.fcad282.. 10.1093/braincomms/fcad282
Gooch, E. A., Horne, K.-L., Melzer, T. R., McAuliffe, M. J., MacAskill, M., Dalrymple‐Alford, J. C., Anderson, T.J., Theys, C. (2023). Acquired Stuttering in Parkinson's Disease. Movement Disorders Clinical Practice. 10.1002/mdc3.13758
Kerestes, R., Laansma, M., ..., Anderson, T., ..., Dalrymple-Alford, J., ..., Melzer, T., ..., Pitcher, T., ..., the ENIGMA-Parkinson's Study (2023). Cerebellar Volume and Disease Staging in Parkinson's Disease: An ENIGMA-PD Study. Movement Disorders. 10.1002/mds.29611
MacAskill, M. R., Pitcher, T. L., Melzer, T. R., Myall, D. J., Horne, K.-L., Shoorangiz, R., Almuqbel, M. M., Livingston, L., Grenfell, S., Pascoe, M. J., Marshall, E. T., Marsh, S., Perry, S. E., Meissner, W. G., Theys, C., Le Heron, C. J., Keenan, R. J., Dalrymple-Alford, J. C., Anderson, T. J. (2023). The New Zealand Parkinson’s Progression Programme. Journal of the Royal Society of New Zealand, 53, 466-488. 10.1080/03036758.2022.2111448
Morris, L. A., Harrison, S. J., Melzer, T. R., Dalrymple-Alford, J. C., Anderson, T. J., MacAskill, M. R., Le Heron, C. J. (2023). Altered nucleus accumbens functional connectivity precedes apathy in Parkinson’s disease. Brain, awad113. 10.1093/brain/awad113
Sevitz, J. S., Perry, S. E., Borders, J. C., Dakin, A. E., Curtis, J. A., Troche, M. S. (2023). The relationship between lingual strength and functional swallowing outcomes in Parkinson’s disease. Dysphagia, 38, 1169–1183. 10.1007/s00455-022-10543-0
Thompson, N., MacAskill, M., Pascoe, M., Anderson, T., Heron, C. L. (2023). Dimensions of apathy in Parkinson’s disease. Brain and Behaviour, e2862, 1-8. 10.1002/brb3.2862
Troche, M. S., Borders, J. C., Curtis, J. A., Dakin, A. E., Sevitz, J. S., Perry, S. E., Vanegas-Arroyave, N., Hegland, K. W. (2023). Rehabilitating Cough Dysfunction in Parkinson’s Disease: A Randomized Controlled Trial. Movement Disorders, 38(2), 201-211. 10.1002/mds.29268
Wang, P., Lan, G., Xu, B., Yu, Z., Tian, C., Lei, X., Meissner, W.G., Feng, T., Yang, Y., Zhang, J., 2023. α-Synuclein-carrying astrocytic extracellular vesicles in Parkinson pathogenesis and diagnosis. Translational Neurodegeneration, 12(1), p.40. (2023). Wang, P., Lan, G., Xu, B., Yu, Z., Tian, C., Lei, X., ... & Zhang, J. (2023). α-Synuclein-carrying astrocytic extracellular vesicles in Parkinson pathogenesis and diagnosis. Translational Neurodegeneration, 12(1), 40. 10.1186/s40035-023-00372-y
2022
Boel, J. A., Bie, R. M. A., Schmand, B. A., Dalrymple‐Alford, J. C., Marras, C., Adler, C. H., Goldman, J. G., Tröster, A. I., Burn, D. J., Litvan, I., Geurtsen, G. J., the MDS Study Group Mild Cognitive Impairment in Parkinson’s Disease (2022). Level I PD‐MCI using global cognitive tests and the risk for Parkinson’s disease dementia. Movement Disorders Clinical Practice, 9(4), 479-483. 10.1002/mdc3.13451
Bronstein, A. M., Anderson, T. J., Kaski, D., MacAskill, M. R., Shaikh, A. (2022). Oculomotor and visuo-vestibular function in Parkinson’s disease. In N. Gálvez-Jiménez, A. D. Korczyn, & R. Lugo-Sanchez (Eds). Non-Motor Parkinson’s Disease, Cambridge University Press.
Kalampokini, S., Hommel, A. L., Lorenzl, S., Ferreira, J. J., Meissner, W. G., Odin, P., Bloem, B. R., Dodel, R., Schrag, A. E. (2022). Caregiver burden in late-stage parkinsonism and its associations. Journal of Geriatric Psychiatry and Neurology. 10.1177/0891988720968263
Kassavetis, P., Kaski, D., Anderson, T. J., Hallett, M. (2022). Eye movement disorders in movement disorders. Movement Disorders Clinical Practice, 9(3), 284-295. 10.1002/mdc3.13413
Khwaounjoo, P., Singh, G., Grenfell, S., Özsoy, B., MacAskill, M. R., Anderson, T. J., Çakmak, Y. O. (2022). Non-contact hand movement analysis for optimal configuration of smart sensors to capture Parkinson’s disease hand tremor. Sensors, 22, 4613. 10.3390/s22124613
Le Heron, C. J. (2022). Reward and actions and the game of life. Journal of Neurology, Neurosurgery & Psychiatry, 93, 458. 10.1136/jnnp-2021-328302
Le Heron, C., MacAskill, M. R., Myall, D. J. (2022). Reply to: “An Exponential Rather Than Multistep Model of Parkinson’s Disease Pathogenesis”. Movement Disorders, 37(5), 1107. 10.1002/mds.28989
Perry, S. E., Borders, J. C., Dakin, A. E., Troche, M. S. (2022). Characterizing quality of life in caregivers of people with Parkinson’s disease and dysphagia. Dysphagia, 523–532. 10.1007/s00455-021-10299-z
2021
Blakemore, R. L., Pascoe, M. J., Horne, K. L., Livingston, L., Young, B. N., Elias, B., Goulden, M., Grenfell, S., Myall, D. J., Pitcher, T. L., Dalrymple-Alford, J. C., Le Heron, C. J., Anderson, T. J., MacAskill, M. R. (2021). Higher perceived stress and exacerbated motor symptoms in Parkinson's disease during the COVID-19 lockdown in New Zealand. The New Zealand Medical Journal, 134, 44-51.
Horne, K., MacAskill, M. R., Myall, D. J., Livingston, L., Grenfell, S., Pascoe, M. J., Young, B., Shoorangiz, R., Melzer, T. R., Pitcher, T. L., Anderson, T. J., Dalrymple‐Alford, J. C. (2021). Neuropsychiatric symptoms are associated with dementia in Parkinson’s disease but not predictive of it. Movement Disorders Clinical Practice, 8, 390-399. 10.1002/mdc3.13151
Laansma, M. A., Bright, J. K., Al‐Bachari, S., Anderson, T. J., Ard, T., Assogna, F., Baquero, K. A., Berendse, H. W., Blair, J., Cendes, F., Dalrymple‐Alford, J. C., Bie, R. M. A., Debove, I., Dirkx, M. F., Druzgal, J., Emsley, H. C. A., Garraux, G., Guimarães, R. P., Gutman, B. A., Helmich, R. C., Klein, J. C., Mackay, C. E., McMillan, C. T., Melzer, T. R., Parkes, L. M., Piras, F., Pitcher, T. L., Poston, K. L., Rango, M., Ribeiro, L. F., Rocha, C. S., Rummel, C., Santos, L. S. R., Schmidt, R., Schwingenschuh, P., Spalletta, G., Squarcina, L., Heuvel, O. A., Vriend, C., Wang, J., Weintraub, D., Wiest, R., Yasuda, C. L., Jahanshad, N., Thompson, P. M., Werf, Y. D., The ENIGMA‐Parkinson’s Study. (2021). International multicenter analysis of brain structure across clinical stages of Parkinson’s disease. Movement Disorders , 36, 2583-2594. 10.1002/mds.28706
Le Heron, C., MacAskill, M.R., Mason, D., Dalrymple-Alford, J., Anderson, T.J., Pitcher, T., Myall, D.J. (2021). A multi-step model of Parkinson’s disease pathogenesis. Movement Disorders, 36, 2530-2538. 10.1002/mds.28719
Le Heron, C., Myall, D., Anderson, T. (2021). Progression in Parkinson’s disease: a potpourri of plots and probabilities. Brain, 3, 708–711. 10.1093/brain/awab060
Nabais, M. F., Laws, S. M., Lin, T., Vallerga, C. L., ..., Anderson, T. J., Bentley, S. R., Dalrymple-Alford, J., Fowder, J., Gratten, J., Halliday, G., Hickie, I. B., Kennedy, M., Lewis, S. J. G., Montgomery, G. W., Pearson, J., Pitcher, T. L., Silburn, P., Zhang, F., Visscher, P. M., Yang, J., Stevenson, A. J., Hillary, R. F., Marioni, R. E., Harris, S. E., Deary, I. J., Jones, A. R., Shatunov, A., Iacoangeli, A., van Rheenen, W., van den Berg, L. H., Shaw, P. J., Shaw, C. E., Morrison, K. E., Al-Chalabi, A., Veldink, J. H., Hannon, E., Mill, J., Wray, N. R., McRae, A. F. (2021). Meta-analysis of genome-wide DNA methylation identifies shared associations across neurodegenerative disorders. Genome Biology, 22, 90. 10.1186/s13059-021-02275-5
Perry, S. E., Troche, M. S. (2021). Dual tasking influences cough reflex outcomes in adults with Parkinson’s disease: a controlled study. Dysphagia, 36, 959-973. 10.1007/s00455-020-10223-x
Wilson, D., Hallett, M., Anderson, T. (2021). An eye on movement disorders. Movement Disorders Clinical Practice, 8, 1168–1180. 10.1002/mdc3.13317
Wilson, D., Le Heron, C., Anderson, T. (2021). Corticobasal syndrome: a practical guide. Practical Neurology, 21, 276–285. 10.1136/practneurol-2020-002835
2020
Adrianus, L., Meinders, M., Weerkamp, N., Richinger, C., Schmotz, C., Lorenzl, S., Dodel, R., Coelho, M., Ferreira, J., Tison, F., Boraud, T., Meissner, W. G., Rosqvist, K., Timpka, J., Odin, P., Wittenberg, M., Bloem, B., Koopmans, R., Schrag, A. (2020). Optimizing treatment in undertreated late-stage parkinsonism: a pragmatic randomized trial. Journal of Parkinson’s Disease, 10, 1171-1184. 10.3233/JPD-202033
Alamri, Y., Dalrymple-Alford, J., MacAskill, M. R., Anderson, T. J. (2020). Exploring eye movements of Parkinson’s disease patients performing the Judgement of Line Orientation test. Journal of Clinical Neuroscience, 76, 183-188. 10.1016/j.jocn.2020.04.031
Alamri, Y., Pitcher, T. L., Anderson, T. J. (2020). Variations in the patterns of prevalence and therapy in Australasian Parkinson’s disease patients of different ethnicities. BMJ Neurology Open, 2(1), e000033.. 10.1136/bmjno-2019-000033
Delamarre, A., Rigalleau, V., Meissner, W. G. (2020). Insulin resistance, diabetes and Parkinson’s disease: the match continues. Parkinson’s and Related Disorders, 80, 199-200. 10.1016/j.parkreldis.2020.10.013
Fan, D., Pitcher, T. L., Dalrymple-Alford, J., MacAskill, M. R., Anderson, T. J., Guan, J. (2020). Changes of plasma cGP/IGF‐1 molar ratio with age is associated with cognitive status of Parkinson disease. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 12, e12025. 10.1002/dad2.12025
Graham, O. E., Pitcher, T. L., Liau, Y., Miller, A. L., Dalrymple-Alford, J. C., Anderson, T. J., Kennedy, M. A. (2020). Nanopore sequencing of the glucocerebrosidase (GBA) gene in a New Zealand Parkinson's disease cohort. Parkinsonism & Related Disorders, 70, 36-41. 10.1016/j.parkreldis.2019.11.022
Grimm, M. J., Respondek, G., Stamelou, M., Arzberger, T., Ferguson, L., Gelpi, E., Giese, A., Grossman, M., Irwin, D., Pantelyat, A., Rajput, A., Roeber, S., van Swieten, J., Troakes, C., Meissner, W. G., Nilsson, C., Piot, I., Compta, Y., Rowe, J., Höglinger, G. (2020). Clinical conditions “Suggestive of Progressive Supranuclear Palsy” — diagnostic performance. Movement Disorders, 35, 2301-2313. 10.1002/mds.28263
Hommel, A. L., Meinders, M. J., Lorenzl, S., Dodel, R., Coelho, M., Ferreira, J. J., Laurens, B., Spampinato, U., Meissner, W. G., Rosqvist, K., Timpka, J., Odin, P., Wittenberg, M., Bloem, B., Koopmans, R., Schrag, A., Care of Late‐Stage Parkinsonism Consortium. (2020). The prevalence and determinants of neuropsychiatric symptoms in late‐stage parkinsonism. Movement Disorders Clinical Practice, 7, 531-542. 10.1002/mdc3.12968
Hommel, A. L., Meinders, M. J., Weerkamp, N. J., Richinger, C., Schmotz, C., Lorenzl, S., Dodel, R., Coelho, M., Ferreira, J., Tison, F, Boraud, T., Meissner, W. G., Rosqvist, K., Timpka, J., Odin, P., Wittenberg, M., Bloem, B., Koopmans, R., Schrag, A. (2020). Optimizing treatment in undertreated late-stage parkinsonism: a pragmatic randomized trial. Journal of Parkinson's disease, . 10.3233/JPD-202033
Horne, K.-L., MacAskill, M. R., Myall, D., Livingston, L., Grenfell, S., Pascoe, M. J., Young, B., Shoorangiz, R., Melzer, T. R., Pitcher, T. L., Anderson, T. J., Dalrymple-Alford, J. C. (2020). Neuropsychiatric symptoms are associated with dementia in Parkinson’s disease but not predictive of it. MedRxiv, 2020, 09, 01, 20186312. https://doi.org/10.1101/2020.09.01.20186312
Le Heron, C., Kolling, N., Plant, O., Kienast, A., Janska, R., Ang, Y. S., Fallson, S., Husain, M., Apps, M. A. (2020). Dopamine modulates dynamic decision-making during foraging. Journal of Neuroscience, 40, 5273–5282. 10.1523/JNEUROSCI.2586-19.2020
Lopez‐Cuina, M., Guerin, P. A., Canron, M. H., Delamarre, A., Dehay, B., Bezard, E., Meissner, W. G., Fernagut, P. O. (2020). Nilotinib fails to prevent synucleinopathy and cell loss in a mouse model of multiple system atrophy. Movement Disorders, 35, 1163-1172. 10.1002/mds.28034
MacAskill, M. R., Myall, D. J., Shoorangiz, R., Anderson, T. J., Pitcher, T. L. (2020). Childbirth and delayed Parkinson’s onset: a reproducible non-biological artefact of societal change. Movement Disorders, 35, 1268-1271. 10.1002/mds.28135
Markaki, I., Bergström, S., Tsitsi, P., Remnestål, J., Månberg, A., Hertz, E., Paslawski, W., Sorjonen, K., Uhlén, M., Mangone, G., Carvalho, S., Rascol, O., Meissner, W. G., Magnin, E., Wüllner, U., Corvol, J., Nilsson, P., Svenningsson, P. (2020). Cerebrospinal fluid levels of Kininogen‐1 indicate early cognitive impairment in Parkinson's disease. Movement Disorders, 35, 2101-2106. 10.1002/mds.28192
Meissner, W. G., Höglinger, G. U. (2020). Looking into the prediagnostic phase of progressive supranuclear palsy. Parkinsonism and Related Disorders, 74. 10.1016/j.parkreldis.2020.04.006
Meissner, W. G., Traon, A. P. L., Foubert‐Samier, A., Galabova, G., Galitzky, M., Kutzelnigg, A., ... , Rascol, O. (2020). A Phase 1 randomized trial of specific active α‐synuclein immunotherapies PD01A and PD03A in multiple system atrophy. Movement Disorders, 35, 1957-1965. 10.1002/mds.28218
Painous, C., van Os, N. J. H., Delamarre, A., Michailoviene, I., Marti, M. J., van de Warrenburg, B. P., Meissner, W. G., …, Tijssen, M. A. (2020). Management of rare movement disorders in Europe: outcome of surveys of the European Reference Network for Rare Neurological Diseases. European Journal of Neurology, 27, 1493-1500. 10.1111/ene.14302
Phokaewvarangkul, O., Vorachit, S., Phoumindr, A., Keosodsay, S., Postuma, R. B., Meissner, W. G., Bhidayasiri, R. (2020). Addressing knowledge gaps in Parkinson’s disease: a report on the Movement Disorder Society’s Centre-to-Centre initiative to improve Parkinson’s disease services in Lao People’s Democratic Republic. BMC Medical Education, 20, 1-7. 10.1186/s12909-020-02161-x
Rascol, O., Negre-Pages, L., Damier, P., Delval, A., Derkinderen, P., Destée, A., Fabbri, M., Meissner, W.G., Rachdi, A., Tison, F. and Perez-Lloret, S. (2020). Utilization patterns of amantadine in Parkinson’s disease patients enrolled in the French COPARK study. Drugs & Aging, 37, 215-223. 10.1007/s40266-019-00740-2
Respondek, G., Grimm, M. J., Piot, I., Arzberger, T., Compta, Y., Englund, E., Ferguson, L., Gelpi, E., Roeber, S., Giese, A., Grossman, M., Irwin, D., Meissner, W. G., Nilsson, C., Pantelyat, A., Rajput, A., van Swieten, J., Troakes, C., Höglinger, G., Whitwell, J. L. (2020). Validation of the Movement Disorder Society criteria for the diagnosis of 4‐repeat tauopathies. Movement Disorders, 35, 171-176. 10.1002/mds.27872
Schierding, W., Farrow, S., Fadason, T., Graham, O. E. E., Pitcher, T. L., Qubisi, S., Davidson, A. J., Perry, J. K., Anderson, T. J., Kennedy, M. A., Cooper, A., O’Sullivan, J. M. (2020). Common variants coregulate expression of GBA and modifier genes to delay Parkinson’s disease onset. Movement Disorders, 28144. 10.1002/mds.28144
Spencer, E. S., Pitcher, T., Veron, G., Hannam, T., MacAskill, M., Anderson, T., Dalrymple-Alford, J. C., Carr, A. C. (2020). Positive association of ascorbate and inverse association of urate with cognitive function in people with Parkinson’s disease. Antioxidants, 9, 906. 10.3390/antiox9100906
Vallerga, C., Zhang, F., Fowdar, J., McRae, A., Qi, T., Nabais, M., Zhang, Q., Kassam, I., Henders, A., Wallace, L., Montgomery, G., Chuang, Y-H., Horvath, S., Ritz, B., Halliday, G., Hickie, I., Kwok, J., Pearson, J., Pitcher, T., Kennedy, M., Bentley, S., Silburn, P., Yang, J., Wray, N., Lewis, S., Anderson, T., Dalrymple-Alford, J., Mellick, G., Visscher, P., Gratten, J. (2020). Analysis of DNA methylation associates the cystine-glutamate antiporter SLC7A11 with risk of Parkinson’s disease. Nature Communications , 11 (1238), 1-10. 10.1038/s41467-020-15065-7
Yu, Z., Shi, M., Stewart, T., Fernagut, P. O., Huang, Y., Tian, C., …, Meissner, W.G., Zhang, J. (2020). Reduced oligodendrocyte exosome secretion in multiple system atrophy involves SNARE dysfunction. Brain, 143, 1780-1797. 10.1093/brain/awaa110
2019
Alamri Y., Pascoe M. J., MacAskill M. R., Anderson T. J., Dalrymple-Alford J. C. (2019). Sensorimotor integration assessment by the Symbol-Digit modalities test in patients with Parkinson’s disease. Neurosciences 24, 143. 10.17712/nsj.2019.2.20190002
Blakemore, R. L., MacAskill, M. R., Myall, D. J., Anderson, T. J. (2019). Volitional suppression of parkinsonian resting tremor. Movement Disorders Clinical Practice, 6, 470-478. 10.1002/mdc3.12801
Blauwendraat, C., Heilbron, K., Vallerga, C. L., Bandres‐Ciga, S., von Coelln, R., Pihlstrøm, L., Siitonen, A., International Parkinson's Disease Genomics Consortium (2019). Parkinson’s disease age at onset genome‐wide association study: Defining heritability, genetic loci, and α‐synuclein mechanisms. Movement Disorders, 34(6), 866-875. 10.1002/mds.27659
Chundru, V. K., Marioni, R. E., Prendergast, J. G. D., Vallerga, C. L., Lin, T., Beveridge, A. J., SGPD Consortium,... Visscher, P. M., McRae, A. F. (2019). Examining the impact of imputation errors on fine-mapping using DNA methylation QTL as a model trait. Genetics. 10.1534/genetics.118.301861
Delamarre, A., Tison, F., Li, Q., Galitzky, M., Rascol, O., Bezard, E., Meissner, W. G. (2019). Assessment of plasma creatine kinase as biomarker for levodopa-induced dyskinesia in Parkinson’s disease. Journal of Neural Transmission, 126, 789-793. 10.1007/s00702-019-02015-x
Grimm, M. J., Respondek, G., Stamelou, M., Arzberger, T., Ferguson, L., Gelpi, E., Giese, A., Grossman, M., Irwin, D. J., Pantelyat, A., Rajput, A., Roeber, S., van Swieten, J. C., Troakes, C., Antonini, A., Bhatia, K. P., Colosimo, C., van Eimeren, T., Kassubek, J., Levin, J., Meissner, W. G., Nilsson, C., Oertel, W. H., Piot, I., Poewe, W., Wenning, G. K., Boxer, A., Golbe, L. I., Josephs, K. A., Litvan, I., Morris, H. R., Whitwell, J. L., Compta, Y., Corvol, J. C., Lang, A. E., Rowe, J. B., Höglinger, G. U., Movement Disorder Society-endorsed PSP Study Group (2019). How to apply the Movement Disorder Society criteria for diagnosis of progressive supranuclear palsy. Movement Disorders. 10.1002/mds.27666
Hoogland, J., Boel, J. A., de Bie, R. M. A., Schmand, B. A., Geskus, R. B., Dalrymple-Alford, J. C., … on behalf of the MDS Study Group “Validation of Mild Cognitive Impairment in Parkinson Disease”. (2019). Risk of Parkinson’s disease dementia related to level I MDS PD-MCI. Movement Disorders. 10.1002/mds.27617
Le Heron, C. J., Holroyd, C., Salamone, J., Husain, M. (2019). Brain mechanisms underlying apathy. Journal of Neurology, Neurosurgery and Psychiatry, 90, 302-312. 10.1136/jnnp-2018-318265
Melzer, T. R., Stark, M. R., Keenan, R. J., Myall, D. J., MacAskill, M. R., Pitcher, T. L., Livingston, L., Grenfell, S., Horne, K., Young, B., Pascoe, M., Almuqbel, M. A., Wang, J., Marsh, S., Miller, D. H., Dalrymple-Alford, J. C., Anderson, T. J. (2019). Beta amyloid deposition is not associated with cognitive impairment in Parkinson’s disease. Frontiers in Neurology, 10, 391. 10.3389/fneur.2019.00391
Nalls, M. A., Blauwendraat, C., Vallerga, C. L., Heilbron, K., Bandres-Ciga, S., Chang, D., and the System Genomics of Parkinson’s Disease Consortium and the International Parkinson’s Disease Genomics Consortium (2019). Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies. The Lancet Neurology, 18(12), 1091-1102. 10.1016/S1474-4422(19)30320-5
Reynolds, R. H., Botía, J., Nalls, M. A., International Parkinson’s Disease Genomics Consortium (IPDGC), System Genomics of Parkinson’s Disease (SGPD), Hardy, J., Taliun, S. A. G., Ryten, M. (2019). Moving beyond neurons: the role of cell type-specific gene regulation in Parkinson’s disease heritability. npj Parkinson's Disease, 5, 1-14. 10.1038/s41531-019-0076-6
Vergnet, S., Hives, F., Foubert-Samier, A., Payoux, P., Fernandez, P., Meyer, M., ..., Meissner, W. G. (2019). Dopamine transporter imaging for the diagnosis of multiple system atrophy cerebellar type. Parkinsonism & Related Disorders. 10.1016/j.parkreldis.2019.02.006
Zhang, Q., Vallerga, C. L., Walker, R. M., Lin, T., Henders, A. K., Montgomery, G. W., Kennedy, M. K., Pitcher, T. L., Pearson, J., Halliday, G., Lewis, S., Anderson, T. J., ..., Visscher, P. M. (2019). Improved precision of epigenetic clock estimates across tissues and its implication for biological ageing. Genome Medicine, 11. 10.1186/s13073-019-0667-1
2018
Ang, Y. S., Manohar, S., Plant, O., Kienast, A., Le Heron, C., Muhammed, K., Hu, M., Husain, M. (2018). Dopamine modulates option generation for behavior. Current Biology, 28, 1561-1569. 10.1016/j.cub.2018.03.069
Blakemore, R. L., MacAskill, M. R., Shoorangiz, R., Anderson, T. J. (2018). Stress-evoking emotional stimuli exaggerate deficits in motor function in Parkinson’s disease. Neuropsychologia, 112, 66-76. 10.1016/j.neuropsychologia.2018.03.006
Fan, D., Alamri, Y., Liu, K., MacAskill, M., Harris, P., Brimble, M., Dalrymple-Alford, J., Prickett, T., Menzies, O., Laurenson, A., Anderson, T., Guan, J. (2018). Supplementation of blackcurrant anthocyanins increased cyclic glycine-proline in the cerebrospinal fluid of Parkinson patients: potential treatment to improve insulin-like growth factor-1 function. Nutrients, 10, 714. 10.3390/nu10060714
Hoogland, J., van Wanrooij, L. L., Boel, J. A., Goldman, J. G., Stebbins, G. T., Dalrymple‐Alford, J. C., ..., & Mollenhauer, B. (2018). Detecting mild cognitive deficits in Parkinson's disease: comparison of neuropsychological tests. Movement Disorders. 10.1002/mds.110
Horne, K. L., Myall, D. J., MacAskill, M. R., Anderson, T. J., Dalrymple-Alford, J. C. (2018). Response to “Parkinson's disease mild cognitive impairment classifications and neurobehavioral symptoms” [letter]. International Psychogeriatrics. 10.1017/S1041610218000091
Le Heron, C., Apps, M. A. J., Husain, M. (2018). The anatomy of apathy: a neurocognitive framework for amotivated behaviour. Neuropsychologia, 118, 54-67. 10.1016/j.neuropsychologia.2017.07.003
Le Heron, C., Plant, O., Manohar, S., Ang, Y. S., Jackson, M., Lennox, G., Hu, M, Husain, M. (2018). Distinct effects of apathy and dopamine on effort-based decision-making in Parkinson’s disease. Brain, 141, 1455-1469. 10.1093/brain/awy110
Pascoe, M. J., Alamri, Y., Dalrymple-Alford, J. C., Anderson, T. J., MacAskill, M. R. (2018). The Symbol-Digit Modalities Test in mild cognitive impairment: evidence from Parkinson's disease patients. European Neurology, 79, 206-210. 10.1159/000485669
Pitcher, T. L., Myall, D. J., Pearson, J. F., Lacey, C. J., Dalrymple-Alford, J. C., Anderson, T. J., MacAskill, M. R. (2018). Parkinson’s disease across ethnicities: a nation-wide study in New Zealand. Movement Disorders, 33, 1440-1448. 10.1002/mds.27389
Wu, L., Liu, F. T., Ge, J. J., Zhao, J., Tang, Y. L., Yu, W. B., Yu, H., Anderson, T. J., Zuo, C. T., Chen, L., Wang, J. (2018). Clinical characteristics of cognitive impairment in patients with Parkinson's disease and its related pattern in 18F‐FDG PET imaging. Human Brain Mapping. 10.1002/hbm.24311
2017
Al-Busaidi, I. S., Anderson, T. J., Alamri, Y. (2017). Qualitative analysis of Parkinson’s disease information on social media: the case of YouTube™. EPMA Journal, 8, 273-277.
Alamri, Y., Anderson, T., Dalrymple-Alford, J., MacAskill, M. (2017). Errors on the MoCA's animal-naming: findings from Parkinson’s disease patients. International Psychogeriatrics, 1-2. 10.1017/S1041610217000345
Bantis, L. E., Nakas, C. T., Reiser, B., Myall, D., Dalrymple-Alford, J. C. (2017). Construction of joint confidence regions for the optimal true class fractions of Receiver Operating Characteristic (ROC) surfaces and manifolds. Statistical Methods in Medical Research, 26, 1429-1442. 10.1177/0962280215581694
Hoogland, J., Boel, J. A., de Bie, R. M. A., Geskus, R. B., Schmand, B. A., Dalrymple-Alford, J. C., Marras, C., Adler, C. H., Goldman, J. G., Tröster, A. I., Burn, D. J., Litvan, I., Geurtsen, G. J., MDS Study Group “Validation of Mild Cognitive Impairment in Parkinson Disease”. (2017). Mild cognitive impairment as a risk factor for Parkinson’s disease dementia. Movement Disorders, 32, 1056-1065. 10.1002/mds.27002
Jones, A. J., Kuijer, R. G., Livingston, L., Myall, D., Horne, K., MacAskill, M., Pitcher, T., Barrett, P. T., Anderson, T. J., Dalrymple-Alford, J. C. (2017). Caregiver burden is increased in Parkinson’s disease with mild cognitive impairment (PD-MCI). Translational Neurodegeneration, 6(17). 10.1186/s40035-017-0085-5
McAuliffe, M. J., Fletcher, A. R., Kerr, S. E., O'Beirne, G. A., Anderson, T. (2017). Effect of dysarthria type, speaking condition, and listener age on speech intelligibility. American Journal of Speech-language Pathology, 26(1), 113-123. 10.1044/2016_AJSLP-15-0182
Myall, D.J., Pitcher, T.L., Pearson, J.F., Dalrymple-Alford, J.C., Anderson, T.J., MacAskill, M.R. (2017). Parkinson's in the oldest old: Impact on estimates of future disease burden. Parkinsonism and Related Disorders, 42, 78-84. 10.1016/j.parkreldis.2017.06.018
Woodward, Z., Prickett, T. C. R., Espiner, E. A., Anderson, T. J. (2017). Central and systemic C-type natriuretic peptide are both reduced in Parkinson’s disease. Parkinsonism & Related Disorders, 43, 15-19. 10.1016/j.parkreldis.2017.06.019
2016
Alamri, Y., MacAskill, M. R., Anderson, T. J. (2016). Repeated lumbar punctures for non-clinical indications: how do patients feel? European Neurology, 76(3-4), 123-124. 10.1159/000449056
Alamri, Y., Vogel, R., MacAskill, M. R., Anderson, T. J. (2016). Plasma exosome concentration may correlate with cognitive impairment in Parkinson’s disease. Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, 4, 107-108. 10.1016/j.dadm.2016.08.002
Almuqbel, M., Melzer, T.R., Myall, D.J., MacAskill, M.R., Pitcher, T.L., Livingston, L., Wood, K., Keenan, R.J., Dalrymple-Alford, J.C., Anderson, T.J. (2016). Metabolite ratios in the posterior cingulate cortex do not track cognitive decline in Parkinson's disease in a clinical setting. Parkinsonism & Related Disorders, 22, 54-61. 10.1016/j.parkreldis.2015.11.008
Guella, I., Evans, D. M., Szu-Tu, C., Nosova, E., Bortnick, S. F., SNCA Cognition Study Group, Goldman, J. G., Dalrymple-Alford, J., Geurtsen, G. J., Litvan, I., Ross, O. A., Middleton, L. T., Parkkinen, L., Farrer, M. J. (2016). α-synuclein genetic variability: A biomarker for dementia in Parkinson's disease. Annals of Neurology, 79, 991-999. 10.1002/ana.24664
MacAskill, M. R., Anderson, T. J. (2016). Eye movements in neurodegenerative diseases. Current Opinion in Neurology, 29, 61-68. 10.1097/WCO.0000000000000274
Mace, J. L., Porter, R. J., Dalrymple-Alford, J. C., Collins, C., Anderson, T. J. (2016). Acute tryptophan depletion and Lewy body dementias. International Psychogeriatrics, 1-5. 10.1017/S1041610216000284
Schluter, P. J., Ahuriri-Driscoll, A., Anderson, T. J., Beere, P., Brown, J., Dalrymple-Alford, J., David, T., Davidson, A., Gillon, D. A., Hirdes, J., Keeling, S., Kingham, S., Lacey, C., Menclova, A. K., Millar, N., Mor, V., Jamieson, H. A. (2016). Comprehensive clinical assessment of home-based older persons within New Zealand: an epidemiological profile of a national cross-section. Australian and New Zealand Journal of Public Health. 10.1111/1753-6405.12525
Wood, K., Myall, D.J., Livingston, L., Melzer, T.R., Pitcher, T.L., MacAskill, M.R., Geurtsen, G.J., Anderson, T.J., Dalrymple-Alford, J.C. (2016). Different PD-MCI criteria and risk of dementia in Parkinson’s disease: Four year longitudinal study. npj Parkinson's Disease, 2, 15027. 10.1038/npjparkd.2015.27
2015
Alamri, Y., Al-Busaidi, I. S., MacAskill, M.R., Anderson, T.J. (2015). Anxiety and depression in Parkinson’s disease patients in Saudi Arabia Global neurology. Journal of the Neurological Sciences, 358, 457-458. 10.1016/j.jns.2015.07.051
Alamri, Y., MacAskill, M., Anderson, T., Benamer, H. (2015). Parkinson’s disease in the Gulf Countries: An updated review. European Neurology, 74(3-4), 222-225. 10.1159/000442283
Anderson, T (2015). How Do I Examine for a Supranuclear Gaze Palsy? Movement Disorders Clinical Practice, 2 (1), 106. 10.1002/mdc3.12116
Martin, T., Weatherall, M., Anderson, T. J., MacAskill, M. R. (2015). A randomised controlled feasibility trial of a specific cueing programme for falls management in patients with Parkinson disease and freezing of gait. Journal of Neurologic Physical Therapy, 39(3), 179-184. 10.1097/npt.0000000000000093
Melzer, T.R., Myall, D.J., MacAskill, M.R., Pitcher, T.L., Livingston, L., Watts, R., Keenan, R.J., Dalrymple-Alford, J.C., Anderson, T.J. (2015). Tracking Parkinson's disease over one year with multimodal magnetic resonance imaging in a group of older patients with moderate disease. PLOS ONE, 10, e0143923. 10.1371/journal.pone.0143923
Wilcox, R., Brænne, I., Brüggemann, N., Winkler, S., Wiegers, K., Bertram, L., Anderson, T., Lohmann, K. (2015). Genome sequencing identifies a novel mutation in ATP1A3 in a family with dystonia in females only. Journal of Neurology, 262(1), 187-93. 10.1007/s00415-014-7547-9
2014
Baylor, C, McAuliffe, MJ, Hughes, LE, Yorkston, K, Anderson, TJ, Kim J, Amtmann, D (2014). A differential item functioning (DIF) analysis of the Communicative Participation Item Bank (CPIB): Comparing individuals with Parkinson's disease from the United States and New Zealand. Journal of Speech Language Hearing Research, 57, 90-95. 10.1044/1092-4388
Espiner, E. A., Dalrymple-Alford, J. C., Prickett, T. C. R., Alamri, Y. , Anderson, T.J. (2014). C-type natriuretic peptide in Parkinson's disease: reduced secretion and response to deprenyl. Journal of Neural Transmission, 121(4), 371-378. 10.1007/s00702-013-1123-9
Le Heron, C. J., Wright, S. L., Melzer, T. R., Myall, D. J., MacAskill, M. R., Livingston, L., Keenan, R. J., Watts, R., Dalrymple-Alford, J. C. , Anderson, T.J. (2014). Comparing cerebral perfusion in Alzheimer's disease and Parkinson's disease dementia: an ASL-MRI study. Journal of Cerebral Blood Flow & Metabolism, 34, 964-970. 10.1038/jcbfm.2014.40
McAuliffe, MJ, Kerr, SE, Gibson, EMR, Anderson, TJ, LaShell, PJ (2014). Cognitive-perceptual examination of remediation approaches to hypokinetic dysarthria. Journal of Speech, Language & Hearing Research, 57, 1268-1283. 10.1044/2014_JSLHR-S-12-0349
Pitcher, T. L., MacAskill, M. R., Anderson, T. J. (2014). Trends in antiparkinsonian medication use in New Zealand: 1995-2011. Parkinson’s Disease, 2014(379431), 1-9. 10.1155/2014/379431
2013
Anderson, T. J., MacAskill, M. R. (2013). Eye movements in patients with neurodegenerative disorders. Nature Reviews Neurology, 9, 74-85. 10.1038/nrneurol.2012.273
Borrie, S. A., McAuliffe, M. J., Liss, J. M., O'Beirne, G. A., Anderson, T. J. (2013). The role of linguistic and indexical information in improved recognition of dysarthric speech. Journal of the Acoustical Society of America, 133, 474-482. 10.1121/1.4770239
MacAskill, M. R., Anderson, T. J. (2013). Whose name is it anyway? Varying patterns of possessive usage in eponymous neurodegenerative diseases. PeerJ, 1(e67). 10.7717/peerj.67
MacAskill, M., Myall, D. , Anderson, T. (2013). "Ocular Tremor" in Parkinson’s Disease: A Technology-dependent Artifact of Universal Head Motion? Movement Disorders, 28, 1165-1166. 10.1002/mds.25602
McAuliffe, M. J., Gibson, E. M., Kerr, S. E., Anderson, T. J., LaShell, P. J. (2013). Vocabulary influences older and younger listeners' processing of dysarthric speech. Journal of the Acoustical Society of America, 134, 1358-1368. 10.1121/1.4812764
Melzer, T. R., Watts, R., MacAskill, M. R., Pitcher, T. L., Livingston, L., Keenan, R., Dalrymple-Alford, J. C., Anderson, T. J. (2013). White matter microstructure deteriorates across cognitive stages in Parkinson disease. Neurology, 80, 1841-1849. 10.1212/WNL.0b013e3182929f62
Nakas, C. T., Dalrymple-Alford, J. C., Anderson, T. J., Alonzo, T.A. (2013). Generalization of Youden index for multiple-class classification problems applied to the assessment of externally validated cognition in Parkinson’s disease screening. Statistics in Medicine, 32(6), 995-1003. 10.1002/sim.5592
van Stockum, S., MacAskill, M. R., Myall, D., Anderson, T. J. (2013). A perceptual discrimination task results in greater facilitation of voluntary saccades in Parkinson’s disease patients. European Journal of Neuroscience, 37(1), 163-172. 10.1111/ejn.12033
2012
Borrie, S., McAuliffe, M., Liss, J., Kirk, C., O'Beirne, G., Anderson, T. (2012). Familiarization conditions and the mechanisms that underlie improved recognition of dysarthic speech. Language & Cognitive Processes, 27, 1039-1055. 10.1080/01690965.2011.610596
Leow, L., Beckert, L., Anderson, T., Huckabee, M. (2012). Changes in chemosensitivity and mechanosensitivity in aging and Parkinson’s disease. Dysphagia, 27, 106-114.
MacAskill, M. R., Graham, C. F., Pitcher, T. L., Myall, D. J., Livingston, L., van Stockum, S., Dalrymple-Alford, J. C., Anderson, T. J. (2012). The influence of motor and cognitive impairment upon visually-guided saccades in Parkinson’s disease. Neuropsychologia, 50, 3338-3347. 10.1016/j.neuropsychologia.2012.09.025
Melzer, T. R., Watts, R., MacAskill, M. R., Pitcher, T. L., Livingston, L., Keenan, R., Dalrymple-Alford, J. C., Anderson, T. J. (2012). Grey matter atrophy in cognitively impaired Parkinson’s disease. Journal of Neurology, Neurosurgery & Psychiatry, 83(2), 188-194. 10.1186/2047-9158-1-17
Pitcher, T. L., Melzer, T. R., MacAskill, M. R., Graham, C. F., Livingston, L., Keenan, R. J., Watts, R., Dalrymple-Alford, J. C., Anderson, T. J. (2012). Reduced striatal volumes in Parkinson’s disease: a magnetic resonance imaging study. Translational Neurodegeneration, 1(1), 17. 10.1186/2047-9158-1-17
van Stockum, S., MacAskill, M. , Anderson, T. (2012). Impairment of voluntary saccades and facilitation of reflexive saccades do not co-occur in Parkinson’s disease. Journal of Clinical Neuroscience, 19, 1119-24. 10.1016/j.jocn.2011.10.014
2011
Dalrymple-Alford, J. C., Livingston, L., MacAskill, M. R., Graham, C., Melzer, T. R., Porter, R., Watts, R., Anderson, T. J. (2011). Characterizing mild cognitive impairment in Parkinson’s disease. Movement Disorders, 26(4), 629-636. 10.1002/mds.23592
Mace, J. L., Porter, R. J., Dalrymple-Alford, J. C., Wesnes, K. A., Anderson, T.J. (2011). The effects of acute tryptophan depletion on neuropsychological function, mood and movement in the healthy elderly. Journal of Psychopharmacology, 25, 1337-1343. 10.1177/0269881110389094
Melzer, T. R., Watts, R., MacAskill, M. R., Pearson, J. F., Rüeger, S., Pitcher, T. L., Livingston, L., Graham, C., Keenan, R., Shankaranarayanan, A., Alsop, D. C., Dalrymple-Alford, J. C., Anderson, T. J. (2011). Arterial spin labelling reveals an abnormal cerebral perfusion pattern in Parkinson’s disease. Brain, 134(3), 845-855. 10.1093/brain/awq377
Trenkwalder, C., Kies, B., Rudzinska, M., Fine, J., Nikl, J., Honczarenko, K., Dioszeghy, P., Hill, D., Anderson, T., Myllyla, V., Kassubek, J., Steiger, M., Zucconi, M., Tolosa, E., Poewe, W., Surmann, E., Whitesides, J. (2011). Rotigotine effects on early morning motor function and sleep in Parkinson's disease: A double-blind, randomized, placebo-controlled study (RECOVER). Movement Disorders, 26, 90-9. 10.1002/mds.23441
van Stockum, S., MacAskill, M. R., Myall, D. , Anderson, T.J. (2011). A perceptual discrimination task abnormally facilitates reflexive saccades in Parkinson's disease. European Journal of Neuroscience, 33, 2091-2100. 10.1111/j.1460-9568.2011.07697.x
2010
Dalrymple-Alford, J. C., MacAskill, M. R., Nakas, C. T., Livingston, L., Graham, C., Crucian, G. P., Melzer, T. R., Kirwan, J., Keenan, R., Wells, S., Porter, R. J., Watts, R., Anderson, T.J. (2010). The MoCA: Well-suited screen for cognitive impairment in Parkinson’s disease. Neurology, 75, 1717-1725. 10.1212/WNL.0b013e3181fc29c9
Leow, L. P., Huckabee, M., Anderson, T., Beckert, L. (2010). The impact of dysphagia on quality of life in aging and Parkinson's disease as measured by the Swallaowing Quality of Life (SWAL-QOL) Questionnaire. Dysphagia, 25(3), 216 - 220. 10.1007/s00455-009-9245-9
Mace, J. L., Porter, R. J., Dalrymple-Alford, J. C., Wesnes, K. A., Anderson, T.J. (2010). The effects of acute tryptophan depletion on neuropsychological function, mood and movement in the healthy elderly. Journal of Psychopharmacology, 24(10), 1465 - 1472. 10.1177/0269881110389094
Mace, J. L., Porter, R. P., Dalrymple-Alford, J., Anderson, T.J. (2010). Effects of acute tryptophan depletion on mood in patients with Parkinson's disease and the healthy elderly. Journal of Psychopharmacology, 24, 615-619. 10.1177/0269881109105721
2009
Mace, J. L., Porter, R. J., Dalrymple-Alford, J. C., Wesnes, K. A., Anderson, T.J. (2009). Effects of acute tryptophan depletion on neuropsychological and motor function in Parkinson’s disease. Journal of Psychopharmacology, 00(00), 1-8. 10.1177/0269881109105721
McKinlay, A., Grace, R. C., Kaller, C. P., Dalrymple-Alford, J. C., Anderson, T. J., Fink, J., Roger, D. (2009). Assessing cognitive impairment in Parkinson's disease: A comparison of two tower tasks. Applied Neuropsychology, 16, 177-185. 10.1080/09084280903098661
2008
Anderson, T., Luxon, L., Quinn, N., Daniel, S., Marsden, C. D., Bronstein, A. (2008). Oculomotor function in multiple system atrophy: clinical and laboratory features in 30 patients. Movement Disorders, 23(7), 977-984. 10.1002/mds.21999
Lim, A., Leow, L., Huckabee, M., Frampton, C., Anderson, T. (2008). A pilot study of respiration and swallowing integration in Parkinson’s "on" and "off" levodopa. Dysphagia, 23(1), 76 - 81. 10.1007/s00455-007-9100-9
McKinlay, A., Grace, R. C., Dalrymple-Alford, J. C., Anderson, T., Fink, J., Roger, D. (2008). A profile of neuropsychiatric problems and their relationship to quality of life for Parkinson’s disease patients without dementia. Parkinsonism & Related Disorders, 14(1), 37-42. 10.1016/j.parkreldis.2007.05.009
McKinlay, A., Grace, R., Dalrymple-Alford, J., Anderson, T., Fink, J., Roger, D. (2008). The accuracy of the Unified Parkinson's Disease Rating Scale (UPDRS-Section 1) as a screening measure for depression. Parkinsonism and Related Disorders, 14(2), 170-172. 10.1016/j.parkreldis.2007.03.002
McKinlay, A., Kaller, C. P., Grace, R. C., Dalrymple-Alford, J. C., Anderson, T. J., Fink, J., Roger, D. (2008). Planning in Parkinson's disease: A matter of problem structure? Neuropsychologia, 46, 384-389. 10.1016/j.neuropsychologia.2007.08.018
Myall, D. J., MacAskill, M. R., Anderson, T. J., Jones, R. D. (2008). Submovements in visually-guided and memory-guided reaching tasks: changes in Parkinson’s disease. In Proceedings of the 30th Annual International Conference of IEEE Engineering in Medicine and Biology Society.
Myall, D. J., MacAskill, M. R., Davidson, P. R., Anderson, T. J. , Jones, R.D. (2008). Design of a modular and low-latency virtual-environment platform for applications in motor adaptation research, neurological disorders, and neurorehabilitation. IEEE Transactions on Neural Systems and Rehabilitation Engineering, 16, 298-309. r 10.1109/TNSRE.2008.922676
2007
Borrie, S., McAuliffe, M. J., Tillard, G., Ormond, T., Anderson, T., Hornibrook, J. (2007). Effect of the Lee Silverman Voice Treatment (LSVT) on articulation in speakers with Parkinson's disease. New Zealand Journal of Speech-Language Therapy, 62, 29-36.
2005
Le Heron, C. J., MacAskill, M. R. , Anderson, T.J. (2005). Memory-guided saccades in Parkinson's disease: long delays can improve performance. Experimental Brain Research, 161, 293-298. 10.1007/s00221-004-2071-2
2004
Spieth, B., MacAskill, M. R. , Anderson, T.J. (2004). Der Einfluss von Morbus Parkinson auf die Ausfuhrung von Sakkaden [The influence of Parkinson’s disease on the execution of saccades]. Orthoptik Pleoptik, 28, 68-80.
2002
MacAskill, M. R., Anderson, T. J., Jones, R. D. (2002). Adaptive modification of saccade amplitude in Parkinson’s disease. Brain, 125(7), 1570-1582.
MacAskill, M. R., Anderson, T. J., Jones, R. D. (2002). Saccadic adaptation in neurological disorders. Progress in Brain Research, 140, 419-433.
1998
Donaldson, I. , Anderson, T. (1998). Shuffling slowly forwards: recent advances in Parkinson's disease management. New Zealand Medical Journal, 111, 197-198.
1994
Steiger, M. J., El Debas, T., Anderson, T., Findley, L. J. , Marsden, C.D. (1994). Double blind study of the activity and tolerability of cabergoline versus placebo in parkinsonians with motor fluctuations. Journal of Neurology, 243, 68 - 72.
1992
Anderson, T., Ewer, T., Gilchrist, N. , Donaldson, I.M. (1992). A trial of Sinemet CR4 in patients with Parkinson's disease. New Zealand Medical Journal, 105, 81-82.